BioLight Life Sciences Ltd. (BOLT.TA)

ILA 642.0

(1.28%)

Total Liabilities Summary of BioLight Life Sciences Ltd.

BioLight Life Sciences Ltd.'s latest annual total liabilities in 2023 was 3.15 Million ILS , down -5.06% from previous year.
BioLight Life Sciences Ltd.'s latest quarterly total liabilities in 2024 Q2 was 4.4 Million ILS , down 0.0% from previous quarter.
BioLight Life Sciences Ltd. reported annual total liabilities of 3.31 Million ILS in 2022, up 20.52% from previous year.
BioLight Life Sciences Ltd. reported annual total liabilities of 2.75 Million ILS in 2021, down -41.68% from previous year.
BioLight Life Sciences Ltd. reported quarterly total liabilities of 3.15 Million ILS for 2023 Q4, down 0.0% from previous quarter.
BioLight Life Sciences Ltd. reported quarterly total liabilities of 93.56 Million ILS for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of BioLight Life Sciences Ltd. (2023 - 2013)

Historical Annual Total Liabilities of BioLight Life Sciences Ltd. (2023 - 2013)

Year	Total Liabilities	Total Liabilities Growth
2023	3.15 Million ILS	-5.06%
2022	3.31 Million ILS	20.52%
2021	2.75 Million ILS	-41.68%
2020	4.72 Million ILS	-30.6%
2019	6.8 Million ILS	-45.51%
2018	12.48 Million ILS	-25.38%
2017	16.73 Million ILS	-11.48%
2016	18.9 Million ILS	16.61%
2015	16.21 Million ILS	10.3%
2014	14.69 Million ILS	20.23%
2013	12.22 Million ILS	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	4.4 Million ILS	0.0%
2023 Q4	3.15 Million ILS	0.0%
2023 Q2	93.56 Million ILS	0.0%
2023 FY	2.31 Million ILS	-30.25%
2022 Q4	3.31 Million ILS	0.0%
2022 Q2	2.26 Million ILS	0.0%
2022 FY	3.31 Million ILS	20.52%
2021 Q2	2.83 Million ILS	0.0%
2021 Q4	2.21 Million ILS	0.0%
2021 FY	2.75 Million ILS	-41.68%
2020 Q4	4.72 Million ILS	-4.78%
2020 Q1	8.18 Million ILS	20.34%
2020 Q3	4.95 Million ILS	-39.59%
2020 FY	4.72 Million ILS	-30.6%
2020 Q2	8.2 Million ILS	0.26%
2019 Q4	6.8 Million ILS	-33.75%
2019 FY	6.8 Million ILS	-45.51%
2019 Q3	10.27 Million ILS	-6.89%
2019 Q2	11.03 Million ILS	-3.42%
2019 Q1	11.42 Million ILS	-8.53%
2018 Q4	12.48 Million ILS	-14.17%
2018 FY	12.48 Million ILS	-25.38%
2018 Q3	14.54 Million ILS	-14.19%
2018 Q2	16.95 Million ILS	-4.16%
2018 Q1	17.68 Million ILS	5.71%
2017 Q3	20.18 Million ILS	7.49%
2017 FY	16.73 Million ILS	-11.48%
2017 Q1	17.07 Million ILS	-9.66%
2017 Q2	18.77 Million ILS	9.94%
2017 Q4	16.73 Million ILS	-17.09%
2016 FY	18.9 Million ILS	16.61%
2016 Q4	18.9 Million ILS	21.66%
2016 Q3	15.53 Million ILS	0.3%
2016 Q2	15.49 Million ILS	-4.38%
2016 Q1	16.2 Million ILS	-0.05%
2015 Q3	14.36 Million ILS	0.96%
2015 Q4	16.21 Million ILS	12.87%
2015 Q2	14.22 Million ILS	0.0%
2015 FY	16.21 Million ILS	10.3%
2014 FY	14.69 Million ILS	20.23%
2014 Q4	14.69 Million ILS	0.0%
2014 Q2	6.45 Million ILS	0.0%
2013 Q2	5.05 Million ILS	0.0%
2013 Q4	4.89 Million ILS	0.0%
2013 FY	12.22 Million ILS	0.0%

Peer Total Liabilities Comparison of BioLight Life Sciences Ltd.

Name	Total Liabilities	Total Liabilities Difference
Matricelf Ltd	3.7 Million ILA	14.838%